autoimmune diseases Related Content

AI model could predict ulcerative colitis flare-ups and complications after reading biopsies taken during colonoscopies.

Phillip Anderson, Head of Policy at the MS Society UK, describes the need to improve multiple sclerosis treatment, care & support, including access to disease modifying therapies.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, walks us through multiple sclerosis facts & trends.

Imagine a life without insulin: Research is bringing us closer to a cure and could change the lives of diabetes patients

Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.

ImotopesTM: a radically new approach to the treatment of autoimmune diseases – now entering Ph.2 testing in type 1 diabetes.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, describes the main focus of non-melanoma skin cancer, including its steadily rising incidence in the UK.

Researchers have identified why certain cells in the body, known as Th17 cells can go rogue and promote the onset of MS

Rick Goodman, University of Nebraska, discusses food allergy risk assessments for new foods in different countries

Peter Bretscher, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, explores important immunological questions

A new study shows promise for future therapies for blinding eye diseases, uveitis and multiple sclerosis.

Peter Bretscher at the University of Saskatchewan discusses his research in Immunology.

New research finds that COVID vaccines work for 90% of people who are currently immunosuppressed due to their medication.

According to the OCTAVE study, immunocompromised patients presented low immune responses after two doses of the same COVID-19 vaccine.

A new clinical trial will investigate whether a third COVID-19 vaccine dose gives a stronger immune response for people with weakened immune systems.

A group of patient bodies, charities and senior clinicians have urged the Government to approve the use of life-saving COVID-19 antibody treatments.

Dr Babita Agrawal, Professor at the University of Alberta, discusses both the vital present and future roles of vaccines and immunotherapeutics in combatting COVID-19.

Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.

Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.

Cambridge researchers have published their findings on how the immune system could be an early clue for the later development of severe or long COVID.